Showing results (21-30 of 1,561) with videos related to
Sort By:
Pageof 157
Investigational New Drugs|January 1, 1985
Phase II studies of mitoxantrone in patients with primary liver cancerG Falkson, B J CoetzerOncology|November 5, 1999
A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinomaC I Falkson, G FalksonCancer|February 15, 1987
Nasally administered buserelin inducing complete remission of lung metastases in male breast cancerD A Vorobiof, G FalksonSouth African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 6, 1975
Towards curative treatment of advanced Hodgkin's diseaseH C Falkson, G FalksonInvestigational New Drugs|January 1, 1986
Phase II study of 4'-deoxydoxorubicin in advanced colorectal cancerG Falkson, D A VorobiofSouth African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 7, 1985
Gonadotrophin-releasing hormone analogue agonists--a new approach in advanced prostatic cancerB J Thürlimann, G FalksonEuropean Journal of Cancer & Clinical Oncology|December 1, 1986
High-dose medroxyprogesterone acetate in combination with vindesine in advanced breast cancerH C Falkson, G FalksonSouth African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|March 15, 1986
[Prognostic parameters in patients with advanced non-Hodgkin's lymphoma]A P Terblanche, G FalksonJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Intranasal buserelin in the treatment of advanced prostatic cancer: a phase II trialG Falkson, D A VorobiofCancer Chemotherapy and Pharmacology|January 1, 1989
A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomitingG Falkson, A J van ZylPageof 157